ETF Managers Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $796K | Buy |
34,187
+999
| +3% | +$23.2K | 0.03% | 272 |
|
|
2022
Q4 | $840K | Sell |
33,188
-40,888
| -55% | -$1.03M | 0.04% | 181 |
|
|
2022
Q3 | $1.43M | Buy |
74,076
+33,530
| +83% | +$647K | 0.05% | 175 |
|
|
2022
Q2 | $1.06M | Buy |
40,546
+414
| +1% | +$10.8K | 0.03% | 227 |
|
|
2022
Q1 | $1.04M | Buy |
40,132
+576
| +1% | +$14.9K | 0.02% | 275 |
|
|
2021
Q4 | $1.61M | Sell |
39,556
-8,135
| -17% | -$330K | 0.03% | 230 |
|
|
2021
Q3 | $2.06M | Buy |
47,691
+9,332
| +24% | +$403K | 0.04% | 199 |
|
|
2021
Q2 | $1.79M | Sell |
38,359
-798
| -2% | -$37.2K | 0.03% | 232 |
|
|
2021
Q1 | $1.87M | Sell |
39,157
-22,804
| -37% | -$1.09M | 0.03% | 199 |
|
|
2020
Q4 | $1.75M | Sell |
61,961
-6,847
| -10% | -$193K | 0.04% | 207 |
|
|
2020
Q3 | $2.6M | Buy |
68,808
+49,113
| +249% | +$1.85M | 0.08% | 146 |
|
|
2020
Q2 | $715K | Buy |
+19,695
| New | +$715K | 0.03% | 224 |
|